Reuters news agency reported on Friday that the government of Argentina has said it received 904,000 doses of Chinese pharmaceutical company Sinopharm's COVID-19 vaccine in its first delivery on 25 February 2021.
Reportedly, this delivery, part of a deal for one million doses of the COVID-19 vaccine, arrived on a plane of Argentina's state carrier from Beijing late in the evening.
According to Argentina's government, the remaining 96,000 remaining doses of the agreement with Sinopharm will arrive in the next few days.
The Foreign Minister of Argentina, Felipe Sola, tweeted: "Everyone is going to get their vaccine and Argentina will be able to move forward."
Reportedly, the Sinopharm COVID-19 vaccines received will add to the 1.22 million doses of Russia's Sputnik V COVID-19 vaccines Argentina has already received, as well as to the 580,000 doses of Covishield, manufactured by the Indian Serum Institute in conjunction with AstraZeneca and Oxford University.
So far, Argentina has recorded over two million cases of COVID-19, with nearly 52,000 deaths.
Merck launches Phase 3 trial for dengue vaccine candidate V181
BioNet and Bio Farma sign MoU on TdaP vaccine
Dx&Vx accelerates universal COVID-19 vaccine development
Moderna withdraws application for flu-COVID combination vaccine pending additional efficacy data
CTP delivers 18,000 sqm Serbian facility for SCHOTT Pharma to support global expansion
LakeShore Biopharma launches novel packaging solution for YSJA rabies vaccine (Vero cell)
Scancell partners with NHS Cancer Vaccine Launch Pad to accelerate melanoma trial recruitment
Orexo reports positive results for powder-based intranasal vaccine using AmorphOX technology
GC Biopharma's BARYTHRAX receives Korean regulatory approval
GSK grants USD2m to boost adult vaccination efforts
Valneva and LimmaTech begin Phase 2 infant trial for Shigella vaccine candidate S4V2
Circio Holding and Entos Pharmaceuticals collaborate on circular RNA delivery
AKAGERA Medicines completes first cohort in phase 1 SAD/MAD study of AKG-100